4.7 Article

Risk Factors for Disseminated Coccidioidomycosis, United States

Journal

EMERGING INFECTIOUS DISEASES
Volume 23, Issue 2, Pages 308-311

Publisher

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2302.160505

Keywords

-

Funding

  1. Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), USA
  2. NIH Medical Research Scholars Program
  3. NIH

Ask authors/readers for more resources

Of 150,000 new coccidioidomycosis infections that occur annually in the United States, approximate to 1% disseminate; one third of those cases are fatal. Immunocompromised hosts have higher rates of dissemination. We identified 8 patients with disseminated coccidioidomycosis who had defects in the interleukin-12/interferon-gamma and STAT3 axes, indicating that these are critical host defense pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available